
|Articles|November 17, 2014
- November 2014
- Volume 20
- Issue SP16
Merck's Pembrolizumab: Breakthrough in NSCLC
Advertisement
Articles in this issue
almost 11 years ago
Physicians Can Be Leaders in Movement to Compassionate End-of-Life Carealmost 11 years ago
After Delays, Reimbursement Approvals Seen for Diagnostic Testsalmost 11 years ago
Fertility Preservation in Young Cancer Patientsalmost 11 years ago
Merck's Pembrolizumab: Breakthrough in NSCLCNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Maternal, Child Mortality Higher in the US Compared With Majority of High-Income Countries
2
Transforming Psychiatry: The Rise of Prescription Digital Therapeutics
3
Government Shutdown Could Disrupt Health Care Access
4
Colon Cancer Recurrence Risk Nearly Gone After 6 Years, Study Reveals
5